SANUWAVE Health, Inc. (SNWV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q3 '21: 10.6M Q4 '21: 13M Q1 '22: 14.1M Q2 '22: 15.1M Q3 '22: 15.5M Q4 '22: 16.7M Q1 '23: 17.3M Q2 '23: 18.1M Q3 '23: 18.9M Q4 '23: 20.4M Q1 '24: 22.4M Q2 '24: 24.9M Q3 '24: 29.3M Q4 '24: 32.6M Q1 '25: 36.2M Q2 '25: 39.1M Q3 '25: 41.2M Q4 '25: 44.2M Q1 '26: 44.5M Q2 '26: 44.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q3 '21: 7.2M Q4 '21: 8M Q1 '22: 9.3M Q2 '22: 10.2M Q3 '22: 11M Q4 '22: 12.4M Q1 '23: 12.6M Q2 '23: 13.3M Q3 '23: 13.8M Q4 '23: 14.4M Q1 '24: 16.1M Q2 '24: 17.8M Q3 '24: 21.3M Q4 '24: 24.6M Q1 '25: 27.7M Q2 '25: 30.3M Q3 '25: 32.2M Q4 '25: 34.1M Q1 '26: 34.2M Q2 '26: 33.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '21: -24.5M Q4 '21: -14.1M Q1 '22: -11.7M Q2 '22: -10.7M Q3 '22: -9.9M Q4 '22: -9M Q1 '23: -9M Q2 '23: -5M Q3 '23: -3M Q4 '23: -540K Q1 '24: 388K Q2 '24: 1.4M Q3 '24: 3.9M Q4 '24: 4.9M Q1 '25: 6.6M Q2 '25: 6M Q3 '25: 5.5M Q4 '25: 5.5M Q1 '26: 3.8M Q2 '26: 2.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -29.5M Q4 '21: -27.3M Q1 '22: -27.4M Q2 '22: -17.2M Q3 '22: -14.1M Q4 '22: -10.3M Q1 '23: -18.3M Q2 '23: -27.2M Q3 '23: -49.7M Q4 '23: -25.8M Q1 '24: -17.3M Q2 '24: -3.4M Q3 '24: -389K Q4 '24: -31.9M Q1 '25: -33.5M Q2 '25: -39.5M Q3 '25: -8.5M Q4 '25: 12.4M Q1 '26: 17.1M Q2 '26: 15.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 4M 8M 12M Q3 '21: 4M Q4 '21: 5M Q1 '22: 4.8M Q2 '22: 4.9M Q3 '22: 4.5M Q4 '22: 4.3M Q1 '23: 4.7M Q2 '23: 4.8M Q3 '23: 5.1M Q4 '23: 6M Q1 '24: 6.4M Q2 '24: 7.1M Q3 '24: 8M Q4 '24: 8.1M Q1 '25: 8.5M Q2 '25: 8.7M Q3 '25: 9M Q4 '25: 10.1M Q1 '26: 10.3M Q2 '26: 10.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-18M -12M -6M 0 6M 12M 18M Q3 '21: -9.4M Q4 '21: -6.4M Q1 '22: -6.2M Q2 '22: -6.4M Q3 '22: -13.1M Q4 '22: -17.2M Q1 '23: -14.4M Q2 '23: -13.2M Q3 '23: -7.2M Q4 '23: -4.5M Q1 '24: -3.1M Q2 '24: -2.9M Q3 '24: 429K Q4 '24: 2.5M Q1 '25: -162K Q2 '25: 1.5M Q3 '25: 1.3M Q4 '25: 3.9M Q1 '26: 5.8M Q2 '26: 5.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-15M -10M -5M 0 5M 10M 15M Q3 '19: -6.1M Q4 '19: -6.5M Q1 '20: -7.8M Q2 '20: -8.7M Q3 '20: -11.6M Q4 '20: -12.8M Q1 '21: -13.6M Q2 '21: -14.2M Q3 '21: -9.9M Q4 '21: -6.9M Q1 '22: -6.6M Q2 '22: -6.6M Q3 '22: -13.2M Q4 '24: 2M Q1 '25: -700K Q2 '25: -106K Q3 '25: -784K Q4 '25: 1.9M Q1 '26: 4M Q2 '26: 4.2M Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 300M 600M 900M Q1 '20: 296.1M Q2 '20: 299.5M Q3 '20: 384.5M Q1 '21: 518.5M Q2 '21: 518.3M Q3 '21: 518.3M Q1 '22: 525.4M Q2 '22: 872M Q3 '22: 561.1M Q1 '23: 575M Q2 '23: 582.3M Q3 '23: 2.4M Q1 '24: 3.1M Q2 '24: 3.7M Q3 '24: 3.2M Q1 '25: 8.5M Q2 '25: 9.2M Q3 '25: 9.1M Q1 '26: 8.6M Q2 '26: 8.6M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '20: -0.06 Q4 '20: -0.07 Q1 '21: -0.07 Q2 '21: -0.08 Q3 '21: -0.06 Q4 '21: -0.06 Q1 '22: -0.06 Q2 '22: -0.04 Q3 '22: -0.03 Q4 '22: -0.02 Q1 '23: -0.03 Q2 '23: -0.04 Q3 '23: -9.99 Q4 '24: -7.30 Q1 '25: -6.56 Q2 '25: -8.37 Q3 '25: -1.42 Q4 '25: 0.60 Q1 '26: 1.15 Q2 '26: 1.11 Q4 '20 Q3 '21 Q2 '22 Q1 '23 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.